TRGM — Targeted Medical Pharma Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Targeted Medical Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | C2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.81 | 7.3 | 9.56 | 7.11 | 5.26 |
| Cost of Revenue | |||||
| Gross Profit | 6.05 | 4.1 | 6.57 | 4.9 | 3.17 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 14.6 | 13.4 | 13.4 | 9.72 | 7.29 |
| Operating Profit | -5.78 | -6.14 | -3.84 | -2.61 | -2.03 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.65 | -12.8 | -3.67 | -3.83 | -3.07 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.18 | -9.59 | -9.34 | -3.9 | -3.07 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.18 | -9.59 | -9.34 | -3.9 | -3.04 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -4.18 | -9.59 | -9.34 | -3.9 | -3.04 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.19 | -0.433 | -0.392 | -0.148 | -0.112 |
| Dividends per Share |